Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| KUCHERLAPATI RAJU S | Director | 5 | $192.6K | $0 | 2022-11-21 |
| Sannino Alessandro | Lead Project Scientist | 3 | $0 | $0 | 2022-06-08 |
| Chiquette Elaine | Chief Scientific Officer | 5 | $0 | $0 | 2022-06-08 |
| Perks Dominic | Director | 1 | $0 | $0 | 2022-05-06 |
| Pass David A. | Chief Operating Officer | 4 | $0 | $0 | 2022-05-06 |
| Wildman Jane | Director | 1 | $0 | $0 | 2022-05-06 |
| Leider Harry L. | Chief Medical Officer | 4 | $0 | $0 | 2022-05-06 |
| Christopher Clayton | Director | 1 | $0 | $0 | 2022-05-06 |
| Cavanaugh Kathryn | Director | 6 | $0 | $0 | 2022-05-06 |
| FONTEYNE PAUL R. | Director | 1 | $0 | $0 | 2022-05-06 |
| Abraham David | General Counsel | 3 | $0 | $0 | 2022-05-06 |
| Zohar Yishai | President & CEO | 4 | $0 | $0 | 2022-05-06 |
| Maltz Elliot | Chief Financial Officer | 4 | $0 | $0 | 2022-05-06 |
| Bauerlein Alison | Director | 1 | $0 | $0 | 2022-05-06 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| KUCHERLAPATI RAJU S | Director | P Buy | 2022-11-21 | 2022-11-22 | 92,000 | $0.45 | $41.4K | 190,264 | SEC↗ |
| KUCHERLAPATI RAJU S | Director | P Buy | 2022-11-18 | 2022-11-22 | 8,000 | $0.39 | $3.1K | 98,264 | SEC↗ |
| KUCHERLAPATI RAJU S | Director | P Buy | 2022-06-15 | 2022-06-17 | 24,625 | $1.95 | $48.0K | 90,264 | SEC↗ |
| Chiquette Elaine | Chief Scientific Officer | A Award deriv | 2022-06-08 | 2022-06-10 | 80,500 | — | $0 | 80,500 | SEC↗ |
| Sannino Alessandro | Lead Project Scientist | D To issuer deriv | 2022-06-08 | 2022-06-13 | 333,392 | — | $0 | 0 | SEC↗ |
| Sannino Alessandro | Lead Project Scientist | A Award deriv | 2022-06-08 | 2022-06-13 | 333,392 | — | $0 | 333,392 | SEC↗ |
| Chiquette Elaine | Chief Scientific Officer | A Award | 2022-06-08 | 2022-06-10 | 80,500 | — | $0 | 263,079 | SEC↗ |
| Abraham David | General Counsel | A Award deriv | 2022-05-06 | 2022-05-09 | 233,705 | — | $0 | 233,705 | SEC↗ |
| Chiquette Elaine | Chief Scientific Officer | A Award deriv | 2022-05-06 | 2022-05-09 | 148,313 | — | $0 | 148,313 | SEC↗ |
| Leider Harry L. | Chief Medical Officer | A Award deriv | 2022-05-06 | 2022-05-09 | 269,660 | — | $0 | 269,660 | SEC↗ |
| Maltz Elliot | Chief Financial Officer | A Award deriv | 2022-05-06 | 2022-05-09 | 395,501 | — | $0 | 395,501 | SEC↗ |
| Pass David A. | Chief Operating Officer | A Award deriv | 2022-05-06 | 2022-05-09 | 431,456 | — | $0 | 431,456 | SEC↗ |
| Zohar Yishai | President & CEO | A Award deriv | 2022-05-06 | 2022-05-09 | 898,867 | — | $0 | 898,867 | SEC↗ |
| Bauerlein Alison | Director | A Award | 2022-05-06 | 2022-05-09 | 51,095 | — | $0 | 51,095 | SEC↗ |
| Cavanaugh Kathryn | Director | A Award | 2022-05-06 | 2022-05-09 | 48,814 | — | $0 | 61,639 | SEC↗ |
| Abraham David | General Counsel | A Award | 2022-05-06 | 2022-05-09 | 22,732 | — | $0 | 22,732 | SEC↗ |
| Abraham David | General Counsel | A Award | 2022-05-06 | 2022-05-09 | 233,705 | — | $0 | 256,437 | SEC↗ |
| Chiquette Elaine | Chief Scientific Officer | A Award | 2022-05-06 | 2022-05-09 | 148,313 | — | $0 | 182,579 | SEC↗ |
| Chiquette Elaine | Chief Scientific Officer | A Award | 2022-05-06 | 2022-05-09 | 34,266 | — | $0 | 34,266 | SEC↗ |
| Christopher Clayton | Director | A Award | 2022-05-06 | 2022-05-09 | 49,270 | — | $0 | 510,768 | SEC↗ |
| FONTEYNE PAUL R. | Director | A Award | 2022-05-06 | 2022-05-09 | 53,832 | — | $0 | 53,832 | SEC↗ |
| KUCHERLAPATI RAJU S | Director | A Award | 2022-05-06 | 2022-05-09 | 50,639 | — | $0 | 65,639 | SEC↗ |
| Leider Harry L. | Chief Medical Officer | A Award | 2022-05-06 | 2022-05-09 | 10,164 | — | $0 | 10,164 | SEC↗ |
| Leider Harry L. | Chief Medical Officer | A Award | 2022-05-06 | 2022-05-09 | 269,660 | — | $0 | 314,090 | SEC↗ |
| Leider Harry L. | Chief Medical Officer | A Award | 2022-05-06 | 2022-05-09 | 34,266 | — | $0 | 44,430 | SEC↗ |
| Maltz Elliot | Chief Financial Officer | A Award | 2022-05-06 | 2022-05-09 | 5,082 | — | $0 | 5,082 | SEC↗ |
| Maltz Elliot | Chief Financial Officer | A Award | 2022-05-06 | 2022-05-09 | 31,392 | — | $0 | 36,474 | SEC↗ |
| Maltz Elliot | Chief Financial Officer | A Award | 2022-05-06 | 2022-05-09 | 395,501 | — | $0 | 431,975 | SEC↗ |
| Pass David A. | Chief Operating Officer | A Award | 2022-05-06 | 2022-05-09 | 11,841 | — | $0 | 11,841 | SEC↗ |
| Pass David A. | Chief Operating Officer | A Award | 2022-05-06 | 2022-05-09 | 39,922 | — | $0 | 51,763 | SEC↗ |
| Pass David A. | Chief Operating Officer | A Award | 2022-05-06 | 2022-05-09 | 431,456 | — | $0 | 483,219 | SEC↗ |
| Perks Dominic | Director | A Award | 2022-05-06 | 2022-05-09 | 49,270 | — | $0 | 49,270 | SEC↗ |
| Sannino Alessandro | Lead Project Scientist | A Award | 2022-05-06 | 2022-05-09 | 68,966 | — | $0 | 207,143 | SEC↗ |
| Wildman Jane | Director | A Award | 2022-05-06 | 2022-05-09 | 50,182 | — | $0 | 50,182 | SEC↗ |
| Zohar Yishai | President & CEO | A Award | 2022-05-06 | 2022-05-09 | 13,157 | — | $0 | 867,082 | SEC↗ |
| Zohar Yishai | President & CEO | A Award | 2022-05-06 | 2022-05-09 | 48,869 | — | $0 | 915,951 | SEC↗ |
| Zohar Yishai | President & CEO | A Award | 2022-05-06 | 2022-05-09 | 898,867 | — | $0 | 1,814,818 | SEC↗ |
| KUCHERLAPATI RAJU S | Director | P Buy | 2022-01-14 | 2022-01-19 | 15,000 | $6.67 | $100.0K | 15,000 | SEC↗ |
| Cavanaugh Kathryn | Director | J Other deriv | 2022-01-13 | 2022-01-18 | 5,175 | — | $0 | 12,825 | SEC↗ |
| Cavanaugh Kathryn | Director | M Exercise deriv | 2022-01-13 | 2022-01-18 | 12,825 | — | $0 | 0 | SEC↗ |
| Cavanaugh Kathryn | Director | M Exercise | 2022-01-13 | 2022-01-18 | 12,825 | — | $0 | 12,825 | SEC↗ |
| Cavanaugh Kathryn | Director | J Other | 2022-01-13 | 2022-01-18 | 12,825 | — | $0 | 12,825 | SEC↗ |
| Cavanaugh Kathryn | Director | J Other | 2022-01-13 | 2022-01-18 | 12,825 | — | $0 | 0 | SEC↗ |